Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 873


Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.

Tang YM, Stone CD.

Clin J Gastroenterol. 2017 Apr;10(2):112-123. doi: 10.1007/s12328-017-0719-2. Review.


Effects of control interventions on Clostridium difficile infection in England: an observational study.

Dingle KE, Didelot X, Quan TP, Eyre DW, Stoesser N, Golubchik T, Harding RM, Wilson DJ, Griffiths D, Vaughan A, Finney JM, Wyllie DH, Oakley SJ, Fawley WN, Freeman J, Morris K, Martin J, Howard P, Gorbach S, Goldstein EJ, Citron DM, Hopkins S, Hope R, Johnson AP, Wilcox MH, Peto TE, Walker AS, Crook DW; Modernising Medical Microbiology Informatics Group..

Lancet Infect Dis. 2017 Jan 25. pii: S1473-3099(16)30514-X. doi: 10.1016/S1473-3099(16)30514-X. [Epub ahead of print]


Surveillance of Clostridium difficile Infections: Results from a Six-Year Retrospective Study in Nine Hospitals of a North Italian Local Health Authority.

Roncarati G, Dallolio L, Leoni E, Panico M, Zanni A, Farruggia P.

Int J Environ Res Public Health. 2017 Jan 10;14(1). pii: E61. doi: 10.3390/ijerph14010061.


Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.

Lawes T, Lopez-Lozano JM, Nebot CA, Macartney G, Subbarao-Sharma R, Wares KD, Sinclair C, Gould IM.

Lancet Infect Dis. 2017 Feb;17(2):194-206. doi: 10.1016/S1473-3099(16)30397-8.


Characterization of Clostridium difficile PCR-ribotype 018: A problematic emerging type.

Barbanti F, Spigaglia P.

Anaerobe. 2016 Dec;42:123-129. doi: 10.1016/j.anaerobe.2016.10.003.


Molecular types and antimicrobial susceptibility patterns of Clostridium difficile isolates in different epidemiological settings in a tertiary care center in Israel.

Miller-Roll T, Na'amnih W, Cohen D, Carmeli Y, Adler A.

Diagn Microbiol Infect Dis. 2016 Dec;86(4):450-454. doi: 10.1016/j.diagmicrobio.2016.08.021.


Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.

Lo Vecchio A, Lancella L, Tagliabue C, De Giacomo C, Garazzino S, Mainetti M, Cursi L, Borali E, De Vita MV, Boccuzzi E, Castellazzi L, Esposito S, Guarino A.

Eur J Clin Microbiol Infect Dis. 2017 Jan;36(1):177-185. doi: 10.1007/s10096-016-2793-7.


High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana.

Janssen I, Cooper P, Gunka K, Rupnik M, Wetzel D, Zimmermann O, Groß U.

Int J Med Microbiol. 2016 Dec;306(8):652-656. doi: 10.1016/j.ijmm.2016.09.004.


Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis.

Roughead EE, Chan EW, Choi NK, Griffiths J, Jin XM, Lee J, Kimura M, Kimura T, Kubota K, Lai EC, Man KK, Nguyen TA, Ooba N, Park BJ, Sato T, Shin JY, Wang T, Wong IC, Yang YK, Pratt NL.

Expert Opin Drug Saf. 2016 Dec;15(12):1589-1595.


An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study.

van Beurden YH, Dekkers OM, Bomers MK, Kaiser AM, van Houdt R, Knetsch CW, Girbes AR, Mulder CJ, Vandenbroucke-Grauls CM.

PLoS One. 2016 Aug 17;11(8):e0160778. doi: 10.1371/journal.pone.0160778.


Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.

Fawley WN, Davies KA, Morris T, Parnell P, Howe R, Wilcox MH; Clostridium difficile Ribotyping Network (CDRN) Working Group..

Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30295.


Clostridium difficile ribotype 033 colitis in a patient following broad-spectrum antibiotic treatment for KPCproducing Klebsiella pneumoniae infection, Italy.

Grandesso S, Arena F, Eseme FE, Panese S, Henrici De Angelis L, Spigaglia P, Barbanti F, Rossolini GM.

New Microbiol. 2016 Jul;39(3):235-236.


Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis.

Vardakas KZ, Trigkidis KK, Boukouvala E, Falagas ME.

Int J Antimicrob Agents. 2016 Jul;48(1):1-10. doi: 10.1016/j.ijantimicag.2016.03.008. Review.


Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.

López-Ureña D, Quesada-Gómez C, Montoya-Ramírez M, del Mar Gamboa-Coronado M, Somogyi T, Rodríguez C, Rodríguez-Cavallini E.

Emerg Microbes Infect. 2016 May 11;5:e42. doi: 10.1038/emi.2016.38.


Clostridium difficile ribotype 176 - A predictor for high mortality and risk of nosocomial spread?

Polivkova S, Krutova M, Petrlova K, Benes J, Nyc O.

Anaerobe. 2016 Aug;40:35-40. doi: 10.1016/j.anaerobe.2016.05.002.


Risk Factors for Recurrent Clostridium difficile Infection in Pediatric Inpatients.

Schwab EM, Wilkes J, Korgenski K, Hersh AL, Pavia AT, Stevens VW.

Hosp Pediatr. 2016 Jun;6(6):339-44. doi: 10.1542/hpeds.2015-0170.


The role of Clostridium difficile in the paediatric and neonatal gut - a narrative review.

Lees EA, Miyajima F, Pirmohamed M, Carrol ED.

Eur J Clin Microbiol Infect Dis. 2016 Jul;35(7):1047-57. doi: 10.1007/s10096-016-2639-3. Review.


Diarrhoea in the critically ill is common, associated with poor outcome, and rarely due to Clostridium difficile.

Tirlapur N, Puthucheary ZA, Cooper JA, Sanders J, Coen PG, Moonesinghe SR, Wilson AP, Mythen MG, Montgomery HE.

Sci Rep. 2016 Apr 20;6:24691. doi: 10.1038/srep24691.


Molecular and epidemiologic study of Clostridium difficile reveals unusual heterogeneity in clinical strains circulating in different regions in Portugal.

Santos A, Isidro J, Silva C, Boaventura L, Diogo J, Faustino A, Toscano C, Oleastro M.

Clin Microbiol Infect. 2016 Aug;22(8):695-700. doi: 10.1016/j.cmi.2016.04.002.


Supplemental Content

Loading ...
Support Center